Education
About Us
Working with TipRanks
Follow Us
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
Atrium Therapeutics, Inc. (RNA) Ownership Overview
0.74%
Insiders
23.21% Mutual Funds
11.27% Other Institutional Investors
14.12% ETFs
50.65% Public Companies and
Individual Investors
The ownership structure of Atrium Therapeutics, Inc. (RNA) stock is a mix of institutional, retail, and individual investors. Approximately 48.60% of the company’s stock is owned by Institutional Investors, 0.74% is owned by Insiders, and 50.65% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,293,236 | Institution | 8.15% | 896,299,837 | |
| 11,054,075 | Institution | 7.33% | 805,952,608 | |
| 8,641,031 | Institution | 5.73% | 630,017,570 | |
| 6,745,647 | Institution | 4.47% | 491,825,123 | |
| 5,476,741 | Institution | 3.63% | 399,309,186 | |
| 2,621,852 | Institution | 1.74% | 191,159,229 | |
| 2,531,865 | Institution | 1.68% | 184,598,277 | |
| 1,725,195 | Institution | 1.14% | 125,783,967 | |
| 1,417,467 | Institution | 0.94% | 103,347,519 | |
| 1,118,098 | Institution | 0.74% | 81,520,525 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,054,075 | Institution | 7.33% | 805,952,608 | |
| 6,745,647 | Institution | 4.47% | 491,825,123 | |
| 2,621,852 | Institution | 1.74% | 191,159,229 | |
| 2,531,865 | Institution | 1.68% | 184,598,277 | |
| 1,417,467 | Institution | 0.94% | 103,347,519 | |
| 1,118,098 | Institution | 0.74% | 81,520,525 | |
| 922,236 | Institution | 0.61% | 67,240,227 | |
| 689,683 | Institution | 0.46% | 50,284,788 | |
| 633,238 | Institution | 0.42% | 46,169,383 | |
| 595,494 | Institution | 0.40% | 43,417,468 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,524,993 | Institution | 3.00% | 326,387,745 | |
| 3,242,950 | Institution | 2.15% | 233,913,984 | |
| 2,853,587 | Institution | 1.89% | 208,055,028 | |
| 1,526,228 | Institution | 1.01% | 110,086,826 | |
| 1,500,143 | Institution | 1.00% | 109,375,426 | |
| 1,048,750 | Institution | 0.70% | 75,646,338 | |
| 999,058 | Institution | 0.66% | 72,841,319 | |
| 915,025 | Institution | 0.61% | 66,000,753 | |
| 892,421 | Institution | 0.59% | 65,066,415 | |
| 680,865 | Institution | 0.45% | 49,641,867 |
FAQ
Who Owns Atrium Therapeutics, Inc. (RNA)?
According to the latest TipRanks data, approximately 11.27% of the company's stock is held by institutional investors, 0.74% is held by insiders, and 50.65% is held by retail investors.
What percentage of Atrium Therapeutics, Inc. (RNA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.27% of Atrium Therapeutics, Inc. (RNA) stock is held by institutional investors.
What percentage of Atrium Therapeutics, Inc. (RNA) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.65% of Atrium Therapeutics, Inc. (RNA) stock is held by retail investors.
Who owns the most shares of Atrium Therapeutics, Inc. (RNA)?
Vanguard owns the most shares of Atrium Therapeutics, Inc. (RNA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.